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Abstract
Background: Quality assessment of microarray data is an important and often challenging aspect
of gene expression analysis. This task frequently involves the examination of a variety of summary
statistics and diagnostic plots. The interpretation of these diagnostics is often subjective, and
generally requires careful expert scrutiny.
Results:  We show how an unsupervised classification technique based on the Expectation-
Maximization (EM) algorithm and the naïve Bayes model can be used to automate microarray
quality assessment. The method is flexible and can be easily adapted to accommodate alternate
quality statistics and platforms. We evaluate our approach using Affymetrix 3' gene expression and
exon arrays and compare the performance of this method to a similar supervised approach.
Conclusion: This research illustrates the efficacy of an unsupervised classification approach for the
purpose of automated microarray data quality assessment. Since our approach requires only
unannotated training data, it is easy to customize and to keep up-to-date as technology evolves. In
contrast to other "black box" classification systems, this method also allows for intuitive
explanations.
Background
Recently, the MicroArray Quality Control (MAQC) con-
sortium found that most microarray platforms will gener-
ate reproducible data when used correctly by experienced
researchers [1]. Despite this positive result, it has been
suggested that 20% or more of the data available in public
microarray data repositories may be of questionable qual-
ity [2]. For this reason, discriminating between high and
low quality microarray data is of the highest importance,
and several recent publications have dealt with this prob-
lem; detailed reviews are provided by Wilkes et al. [3] and
Eads et al. [4].
Several approaches have emphasized the importance of
measuring, either directly or indirectly, the integrity of the
RNA samples used in the experiment (e.g. [5-7]). Other
research has focused on spatial artifacts: problems that
typically arise during hybridization due to bubbling,
scratches and edge effects [8,9].
In the case of Affymetrix GeneChips, which we will use to
demonstrate our method, there are standard benchmark
tests provided by the manufacturer [10]. A standard com-
plementary approach is to use the R statistical software,
along with the BioConductor [11] "affy" [12] and "affy-
Published: 22 June 2009
BMC Bioinformatics 2009, 10:191 doi:10.1186/1471-2105-10-191
Received: 2 December 2008
Accepted: 22 June 2009
This article is available from: http://www.biomedcentral.com/1471-2105/10/191
© 2009 Howard et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
Page 2 of 14
(page number not for citation purposes)
PLM" [13] packages, to produce a series of diagnostic
plots for the assessment of GeneChip quality (see addi-
tional file 1: Fig S3, S4). A review of the quality control
features available in BioConductor can be found in [14],
and a variety of software packages are now available to
assist in the automation of this process [15-19].
In general, the goal of these approaches is to identify chips
that are outliers – either in relation to other chips in the
same experiment or the entire theoretical population of
similar chips. Often, it is assumed that a rational decision
regarding data quality is made only after considering sev-
eral quasi-orthogonal dimensions of quality. Chips are
typically rejected only after a preponderance of the evi-
dence indicates poor quality; a slightly unusual score on a
single metric is frequently ignored, while a number of
moderately or highly unusual scores on a variety of qual-
ity metrics is often grounds for exclusion of a particular
chip from further analysis. However, there are no univer-
sal, robust thresholds available for the identification of
outliers according to the various quality variables. Instead,
decisions are necessarily made using historical data, either
implicitly or explicitly.
Therefore, recent efforts have focused on providing a
"holistic", accurate, and automatic interpretation of diag-
nostic plots and quality metrics. Burgoon et al. [20]
describe a custom, in-house protocol for assessing data
quality of two-color spotted cDNA arrays. The authors
advocate an integrated "Quality Assurance Plan" which
attempts to integrate quality control at every level of the
experimental procedure.
Another example is the RACE system [15,16]. This system
utilizes various statistics extracted from the BioConductor
diagnostic plots, along with a random forest classifier, to
automatically identify low quality data. However, like the
quality assurance protocol described by Burgoon et al., the
RACE system relies on a large expert-annotated data set.
For this reason, it is difficult to keep the system up-to-date
in the face of rapidly changing technology, with new chip
types continually being introduced into the market. A fur-
ther challenge is to adapt such a system to similar, but
slightly different, types of data such as Affymetrix SNP
arrays, exon arrays, or arrays produced by other manufac-
turers such as Illumina and Agilent.
In this paper we investigate a method for unsupervised
classification that was designed with these considerations
in mind. First, we describe how to frame the interpreta-
tion of microarray quality indicators as an unsupervised
classification problem using a Gaussian mixture model.
We show how the model parameters can be estimated
using the Expectation-Maximization (EM) algorithm [21],
and how they can be used to construct a Naïve Bayes clas-
sifier for identifying low quality data.
Previous work has demonstrated that naïve Bayes classifi-
ers perform well with labeled training sets in the super-
vised version of the problem discussed in this paper [15].
The combination of Naïve Bayes together with EM has
been used with considerable success in other problem
domains, including text classification [22]. Gaussian mix-
ture models have been applied to automatic quality
assessment of phone signal clarity [23] and mass spec-
trometry data [24], and in other stages of the microarray
processing pipe-line, including identification of differen-
tially expressed genes [25], assessment of the concordance
between sets of similar microarray data sets [26], and even
quality control at the spot detection and image fluores-
cence analysis level [27]. However, this is the first research
we are aware of that employs this estimation approach, in
conjunction with a naïve Bayes classifier, for the purpose
of array-level quality control of microarray data.
In the following sections, we describe the datasets used in
this research, and explain the implementation of both the
supervised and unsupervised versions of the quality clas-
sifier. We demonstrate that the performance of the unsu-
pervised classifier is comparable to a supervised classifier
constructed from expert-labeled data. We also apply the
algorithm to Affymetrix exon array data, and compare the
observed quality indicator distributions with those
obtained from 3' expression arrays.
Methods
Datasets
Our first dataset is a set of 603 Affymetrix raw intensity
microarray data files, from 32 distinct experiments down-
loaded from the NCBI GEO database [28]. A variety of
Affymetrix GeneChip 3' Expression array types are repre-
sented in the dataset, including: ath1121501 (Arabidop-
sis, 248 chips; GEO accession numbers: GSE5770,
GSE5759, GSE911 [29], GSE2538 [30], GSE3350 [31],
GSE3416 [32], GSE5534, GSE5535, GSE5530, GSE5529,
GSE5522, GSE5520, GSE1491 [33], GSE2169, GSE2473),
hgu133a (human, 72 chips; GSE1420 [34], GSE1922),
hgu95av2 (human, 51 chips; GSE1563 [35]), hgu95d
(human, 22 chips; GSE1007 [36]), hgu95e (human, 21
chips; GSE1007), mgu74a (mouse, 60 chips; GSE76,
GSE1912 [37]), mgu74av2 (mouse, 29 chips; GSE1947
[38], GSE1419 [39,40]), moe430a (mouse, 10 chips;
GSE1873 [41]), mouse4302 (mouse, 20 chips; GSE5338
[42], GSE1871 [43]), rae230a (rat, 26 chips; GSE1918,
GSE2470), and rgu34a (rat, 44 chips; GSE5789 [44],
GSE1567 [45], GSE471 [46]). These experiments cover
many of the species commonly analyzed using the Gene-
Chip platform, and were selected to represent a variety of
tissue types and experimental treatments.BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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The BioConductor rma() function was used to perform
probeset summarization, background subtraction and
quantile normalization, with each raw intensity (.CEL)
file preprocessed together with the other chips from the
same GEO experiment. A variety of quality control indica-
tors, listed in Table 1, were then computed for each chip.
A list of all the .CEL files and their GEO identifiers, along
with quality control feature scores and expert annotations,
can be found in additional file 2. Also included in the file
are descriptions explaining how each of the 29 quality
control feature scores is computed from the raw expres-
sion data.
The second dataset consists of all of the exon array .CEL
files available in the GEO database at the time of this anal-
ysis (540 .CEL files). Fourteen different experiments are
represented (GSE10599 [47], GSE10666 [48], GSE11150
[49], GSE11344 [50], GSE11967 [51], GSE12064 [52],
GSE6976 [53], GSE7760 [54], GSE7761 [55], GSE8945
[56], GSE9342, GSE9372 [57], GSE9385 [58], GSE9566
[59]). The dataset includes examples of the Mouse Exon
1.0 ST array and several versions of the Human Exon 1.0
ST array. This dataset was processed using two different
methods. First, the same set of quality indicators
described above for the 3' expression dataset was prepared
using the BioConductor packages in R. The "aroma" .cdf
annotation files [60] were used to read in expression val-
ues for the core probes on the arrays. In addition, this sec-
ond dataset was also processed using the Affymetrix
Expression Console software. Only the "core" probesets
were considered and the software was used to perform
"gene-level" probeset summarization, background sub-
traction and quantile normalization using the "RMA
sketch" option in the software. Several alternative quality
indicators were then computed (Table 2). A list of the
.CEL files and their GEO identifiers and also the various
quality control feature scores is included in additional file
3. Detailed descriptions of the Affymetrix Expression Con-
sole quality control features can be found in [61].
Expert Annotation
A domain expert analyzed the 3' expression dataset (data-
set 1) and assigned quality scores according to a procedure
which is based on experience gained during almost three
years of bioinformatics support within the Lausanne DNA
Array Facility (DAFL). This quality control procedure is
described in [15]. Briefly, the chip scan images and the
distributions of the log scale raw PM intensities are visual-
ized. Smaller discrepancies between chips are common
and can often be removed by normalization. Remaining
discrepancies usually indicate low quality data, possibly
caused by problems in the amplification or labelling step.
The general 5' to 3' probe intensity gradient averaged over
all probe sets on a chip is also examined. The slope and
shape of the resulting intensity curves depend on the RNA
sample source, the amplification method, and the array
type. In general, the specific shape of the curves is less
important for the quality check than their agreement
Table 1: BioConductor Quality Control Statistics
Quality Statistic1 Description
mean.raw.int, sd.raw.int, median.raw.int, interQuartile.raw.int mean, standard deviation, median and inter-quartile range of raw log 
intensity distribution.
q.5.raw.int, q.95.raw.int 5th and 95th percentile of raw log intensity distribution.
slope.bias, p.bias slope parameter and associated p-value of linear regression of log 
expression level versus probe number, as computed by R affy library 
function AffyRNAdeg().
mean.norm.int, sd.norm.int, median.norm.int, interQuartile.norm.int, 
q.5.norm.int, q.95.norm.int
mean, standard deviation, median, inter-quartile range, and 5th and 95th 
percentiles of normalized log intensity distribution.
PLM.w.q.0.001, PLM.w.q.0.01, PLM.w.q.0.1, PLM.w.q.0.2 0.1th, 1st, 10th and 20th percentile of the probe-level model weights, 
computed using affyPLM library functionality.
PLM.res.q.0.01, PLM.res.q.0.1, PLM.res.q.0.25, PLM.res.q.0.75, PLM.res.q.0.9, 
PLM.res.q.0.99
1st, 10th, 25th, 75th, 90th, and 99th percentile of probe-level model 
residuals, computed using affyPLM library functionality.
RLE.median, RLE.interQuartile, RLE.lower.whisker, RLE.upper.whisker median, inter-quartile range, lower tail and upper tail of "relative log 
intensity", computed using affyPLM library functionality.
1. The "SCORE" function was used to normalize values for each statistic, t, for each chip, i, relative to the values observed in other chips from the 
same experiment:  ; with median() and mad() computed across all chips in the experiment. SCORE ti
ti median t
mad t ()
()
() =
−BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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across the experiment. Pseudo-images representing the
spatial distribution of residuals and weights derived from
the probeset summarization model are very important
diagnostics. Small artifacts are not critical when using
robust analysis methods; however, extended anomalies
are taken as an indication of low quality. In addition, box
plot representations of the Normalized Un-scaled Stand-
ard Error (NUSE) from the probe level model fit and the
Relative Log Expression (RLE) between each chip and a
median chip are examined. These plots are used to iden-
tify problematic chips showing an overall deviation of
gene expression levels from the majority of all measured
chips. A chip may be judged as having poor quality if it is
an apparent outlier in the experiment-wide comparison of
several quality measures. Each array was given a quality
score of 0, 1 or 2, with 0 being "acceptable quality" (519
chips), 1 being "suspicious quality" (56 chips) and 2
being "unacceptable quality" (28 chips). For the purposes
of classification, chips with scores of 1 or 2 were com-
bined into the composite "low quality" class.
Supervised Naïve Bayes Classifier
Previous research has demonstrated that quality assess-
ment of microarray data can be successfully automated
with the use of a supervised classifier [15,20]. The goal of
supervised classification is to utilize an annotated training
dataset to learn a function that can be used to correctly
classify unlabeled instances. In the case of microarray
quality assessment, the training dataset consists of the
quality control features computed for each chip, com-
bined with the quality annotation for each chip.
By making the simplifying assumption that all features are
conditionally independent, naïve Bayes classifiers attempt
to directly model the probability that a particular data
point belongs to each class. Given the class label, each fea-
ture is assumed to follow an independent, univariate dis-
tribution. These distributions are, of course, unknown,
but the maximum likelihood parameter estimates can be
determined from a labeled training set. Then, for each
unlabeled instance, Bayes' rule can be applied to compute
the conditional probability that the instance belongs to
each of the possible classes. Because we had prior success
performing classification on a similar data set using Naïve
Bayes with Gaussian feature distributions [15], we again
chose to model the features using independent normal
distributions. However, the approach could easily be
adapted to use alternative distributions, for example, Stu-
dent's t-distribution or the skew-normal distribution.
Under this framework, the probability that an unlabeled
instance belongs to the low quality class is estimated as
follows:
where c ∈ {0,1} signifies the class label, with 0 denoting
"high quality" and 1 denoting "low quality,"   is a length
p vector of features describing the unlabeled instance., and
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Table 2: Affymetrix Expression Console Quality Control Statistics (Exon Arrays)
Quality Statistic1 Description
pm.mean mean of the raw intensity for all PM probes, prior to any normalizations.
bgrd.mean mean of the raw intensity for all probes used to compute background intensity. (Note: may 
be higher than pm.mean because GC compositions of probes used to compute background 
and PM probes can be quite different.)
pos.vs.neg.auc area under ROC curve discriminating between positive control probesets and negative 
control probesets.
probeset.mean, probeset.stdev mean and standard deviation of probeset signals after normalization. 2
probeset.mad.residual.mean, probeset.mad.residual.stdev mean and standard deviation of the absolute deviations of the RMA probe level model 
residuals from the median across chips. 2
probeset.rle.mean, probeset.rle.stdev mean and standard deviation of the absolute values of the relative log expression (RLE) for 
all probesets. 2
1. The "SCORE" function was used to normalize values for each statistic, t, for each chip, i, relative to the values observed in other chips from the 
same experiment:  ; with median() and mad() computed across all chips in the experiment.
2. Separate statistics are computed for a) all probesets, b) negative control probesets, and c) positive control probesets.
SCORE ti
ti median t
mad t ()
()
() =
−BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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 is the Gaussian density for the ith feature,
among low quality chips.
The marginal probability of observing a low quality chip,
Pr{c = 1}, can be estimated from the proportion of low
quality chips in the training set. Furthermore, the mar-
ginal density for a particular combination of feature val-
ues,  , independent of the class label, is equal to:
For the purposes of classification, this algorithm assigns
class 1 to an unlabeled instance  , if Pr(c = 1| } > t,
where t is a threshold parameter, ordinarily set to 0.5 in
order to approximate the Bayes optimal decision rule. By
varying this parameter, it is also possible to construct ROC
curves which display the tradeoff between sensitivity and
specificity for various decision thresholds.
Unsupervised Naïve Bayes Classifier
The standard (supervised) approach to constructing a
naïve Bayes classifier employs maximum likelihood esti-
mation to infer the distribution parameters of each classi-
fication feature from an expert-annotated training set. It
is, however, also possible to construct an "unsupervised"
naïve Bayes classifier by using an unannotated dataset as
input. In this case, the EM algorithm is used to infer the
feature distributions, assuming an appropriate Gaussian
mixture model, as described in the following section.
Gaussian Mixture Model and the EM Algorithm
The naïve Bayes classification model described above
requires parameter estimates for the quality control met-
rics, conditional on each quality class. In the absence of
annotated data, however, the quality classes of the unan-
notated training instances are additional unknowns that
must be estimated along with the distributional parame-
ters. We model the unannotated dataset using a Gaussian
Mixture Model, under the assumption that microarray
data can be reasonably classified into the dichotomy of
"high quality" and "low quality" chips, and that the unla-
beled training set contains examples of each.
Given a large set of microarray data files, the first step is to
compute values for each of the various quality control fea-
tures. Then, for each feature, we assume that the observed
distribution of scores is generated by an underlying Gaus-
sian mixture model with two components: 1) chips hav-
ing high quality and 2) chips having low quality. Given
the mixture component, c  ∈ {0,1}, each feature is
assumed to follow a Normal   distribution. How-
ever, in the case of an unlabeled dataset, the true mixture
component is unknown. We further assume that, margin-
ally, the class label for each instance is a simple Bernoulli
random variable with probability φ of indicating a low
quality chip. Under this model, the (log) likelihood of the
dataset is:
where:
￿ x is an N × p matrix containing the p feature values
for the N items in the dataset, with   denoting the
length p feature vector for the ith data point.
￿ μ is a 2 × p parameter matrix containing, in each col-
umn, μ0 and μ1 for the pth feature;   is the length p
parameter vector for the jth Gaussian mixture compo-
nent (j ∈ {0,1}).
￿ σ2 is a 2 × p parameter matrix containing, in each col-
umn,   and   for the pth feature;   is the length p
parameter vector for the jthGaussian mixture compo-
nent.
￿   is a length N vector containing the (unknown)
class labels for each of the N data points.
￿   is a length 2 probability vector containing the
probability that a randomly chosen data point belongs
to each class.
The likelihood function in equation 3 can be maximized
using the EM algorithm [21]. The EM algorithm is a well-
known method for maximizing mixture model likelihood
functions by iteratively performing two steps:
￿ E Step: Estimate the unknown class labels, based on
the current estimates for the other parameters.
fx c
i (| )
() G
=1
fx ()
G
fx fx c c fx
i
p
i
i
p
i () ( | ) P r { } (
() ( GG G
==
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
=
⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥
+
== ∏∏
11
00
) ) |) P r { } cc =
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
==
⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥
11
(2)
G
x
G
x
μσ cc ,
2 ()
log ( , , | ) log( ( ; , , )
log ( | ;
()
Lf x
fx c j
i
i
N
i
i
μ μσ σμ μσ σ
22 G G G
GG G
φφ x =
==
= ∑
1
μ μσ φ jj
i
j i
N
cj ,) P r { ; }
() G G G
2
0
1
1
=
= = ∑ ∑
(3)
G
xi
G
μ j
σ 0
2 σ1
2 G
φ
G
c
G
φBMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
Page 6 of 14
(page number not for citation purposes)
￿ M Step: Given current class labels, compute the max-
imum likelihood estimators for the parameters μ, σ2,
and .
To implement the EM algorithm, we introduce an addi-
tional N  × 2 matrix, w, which contains, for each data
point, i, the current guesses for p(  = 0) and p(  = 1).
After initializing all parameters and the weight matrix, w,
to random values, the EM algorithm proceeds as follows:
M step: For j ∈ {0,1}, k ∈ {1 ... p}
E Step: For i ∈ {1 ... N}, j ∈ {0,1}
where normpdf(x, μ, σ2) denotes the probability density of
a normal distribution evaluated at x. Because the algo-
rithm can possibly converge to local optima, it is prudent
to run the algorithm several times after random restarts.
Additionally, each   was constrained to be > = .001 to
avoid convergence to a trivial solution. Further details
concerning this implementation of the EM algorithm and
the associated Gaussian mixture model can be found in
[62]. Once estimates have been obtained for μ, σ2 and ,
any unlabeled instance can be classified according to
these mixture components using naïve Bayes, according to
equation 1 (or equivalently, equation 7, in the case of the
original unlabeled dataset). Since our assumption is that
low quality chips are outliers with respect to these quality
features, we use the mixture component corresponding to
the smallest value from   to identify the low quality class.
Feature Selection
In order to achieve optimal classification performance, it
is important to select an appropriate subset of the classifi-
cation features. Ideally, this subset should include inde-
pendent features that are each individually predictive of
the class label.
To measure the ability of each feature to predict the cor-
rect class label in a training set (where "correct" label is
defined as either the expert annotation in the supervised
case, or the estimated w matrix in the unsupervised case),
we first constructed an N × p score matrix, S, where each
cell  Sij  contains a distance measuring the discrepancy
between the true and predicted class for data point  ,
given the jth feature and the parameter estimates for that
feature:
Then for each feature, j, these scores were totaled across all
N data points
Finally, the p scores were sorted in ascending order, to
rank the features by their ability to predict the correct class
label. Denote the rank of feature j according to the value
of this score as S[j].
To identify correlations among the quality control fea-
tures, we next computed the p × p Pearson correlation
matrix. Let ρjk denote the correlation between features j
and k, and ρ[j]k represent the rank of the correlation of fea-
ture j with feature k among all other features correlated
with k, with features ranked in order of descending correla-
tion. To select a subset of n features, we used the following
forward selection algorithm:
￿ First, select the single feature that is most predictive
of the class labels, i.e. the feature with S[j] = 1.
￿ Then, sequentially, for the remaining n-1 features,
select the feature j to satisfy:
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where F denotes the set of previously selected features.
The constants c1 and c2 in this expression are weighting
factors that can be modified to control the tradeoff
between selection for independent features and features
that are highly correlated with the class label. We used 0.5
for each.
Results and discussion
Parameter Estimates
3' Expression Arrays
We applied the unsupervised mixture model described
above to the 3' expression array data (hiding the expert
quality labels). For nearly all of the 29 quality control fea-
tures considered, the unsupervised EM parameter esti-
mates very closely approximate the corresponding
supervised MLE estimates, a result which indicates that
the unsupervised approach was able to discover patterns
in the data that are in agreement with the expert annota-
tions. Additional file 4 contains the mixture model
argmin
[]
||
[]
j
j cS
c ji
iF
F
1
2
+ ∈
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⎟
ρ
(10)
Mixture Model Parameter Estimates Figure 1
Mixture Model Parameter Estimates. Supervised (MLE) and Unsupervised (EM) estimates shown are for the following 
features from the 3' expression arrays: (A) 5th percentile of raw intensities, (B) inter-quartile range of the Relative Log Inten-
sity (RLE), (C) 25th percentile of the probe-level model residuals, and (D) the 20th percentile of the probe-level model 
weights. All features were normalized relative to other chips in the same experiment, using the SCORE function (see Table 1).BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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parameter estimates for  , μ0, μ1,   and   for each of
the quality control features. These estimates were
obtained by applying the EM algorithm to the entire unla-
beled dataset. For comparison, the table also includes the
maximum likelihood estimates obtained using the expert-
annotated class labels. Figure 1 shows some representative
examples. Plots of this nature reveal that, in most cases,
the EM and (supervised) MLE estimates exhibit only
minor differences, generally with magnitudes analogous
to the discrepancies shown in Figures 1a–d.
The EM estimates appear to be reasonable in all cases,
given the original intent of each quality metric. For exam-
ple, given the normalized (log-scale) expression values,
the RLE metric measures the distribution of the quantity
 for each chip, where   is the log expres-
sion measurement for probeset g, on chip i, and mg is the
median expression of probeset g across all arrays. In gen-
eral, since it is ordinarily assumed that the majority of
genes are not differentially expressed across chips, the
quantity Mgi is expected to be distributed with median 0.
In addition, chips that more frequently have extreme
expression values will have a large inter-quartile range for
this statistic. Figure 1b indicates that, as expected, low
quality chips were indeed more likely to have a large inter-
quartile range for the RLE statistic.
Parameter estimates for the other metrics also agree with
our expectations. For example, the estimates for metrics
relating to probe-level model weights and residuals reflect
the expectation that low quality chips should have larger
residuals and more down-weighted probesets (Figure 1c,
d). Similarly, the estimates indicate that low quality chips
are more likely to have RNA degradation plots that are dif-
ferent from other chips in the same experiment. The low
quality chips also tend to have both mean raw and mean
normalized intensities that are either significantly higher
or lower than other chips in the same experiment.
Exon Arrays
The Affymetrix exon array platform is different from the 3'
expression array platform in several important ways [63].
For example, the 3' expression array targeting the human
genome (Hgu133) has, on average, 1 probeset pair for
each well-annotated gene; each probeset consists of 11
individual 25-mer probes, which primarily target the 3'
region of the gene. In contrast, the Human Exon 1.0 ST
array has 1 probeset for each exon for each gene in the tar-
get genome. Each probeset contains, in general, 4 (rather
than 11) 25-mer probes. Unlike 3' expression arrays, exon
arrays lack mismatch probes. Instead, the background
expression level for each probe is estimated by averaging
the intensities of approximately 1000 surrogate genomic
and anti-genomic background probes having the same GC
content as the target probe. Because most genes consist of
several exons, the median number of probes per gene is
increased on the exon array from 11 on the 3' array to
between 30–40 [64]. However, genes with fewer exons are
covered by fewer probes. In fact, there are a few thousand
well-annotated single exon genes covered by only 4
probes [63]. Furthermore, the feature size on the exon
arrays has been reduced from 11 × 11 microns on the
HGU133 array to 5 × 5 microns on the Human Exon 1.0
ST array (about 1/5 the area). This change may increase
the expression variance, at least at the probeset level [63].
Exon arrays also utilize a different hybridization protocol
which uses sense-strand labeled targets, and results in
DNA-DNA hybridizations rather than the DNA-RNA
hybridizations used with traditional 3' arrays [65]. These
differences suggest that the distributions of key quality
control indicators may differ between the two platforms.
For the exon arrays, the resulting probability estimate for
low quality chips was .397 – nearly twice what was
obtained for the 3' arrays. This is reflected in Figure 2 as
the larger areas under the red curves for exon arrays com-
pared to 3' arrays, and as the smaller areas under the green
curves for exon arrays compared to 3' arrays. For the
majority of the indicators, the estimated distributions
were qualitatively similar to those estimated for the 3'
arrays (Figure 2a, c, d). One interesting difference is that
in the exon arrays, the low quality chips appear to be more
likely to have median raw intensity values that are lower
than other chips in the same experiment (Figure 2b),
whereas for the 3' arrays, both abnormally high and low
median raw intensities appear to be indicative of bad
chips.
To check the robustness of our estimates, we also analyzed
a separate set of quality control indicators (Table 2) com-
puted using the Affymetrix Expression Console software.
In agreement with the estimate obtained using the first set
of quality metrics, the inferred probability for low quality
chips was .394 using the Expression Console quality indi-
cators. At a qualitative level, the estimates for the Expres-
sion Console quality indicators generally agreed with our
expectations. For example, Figure 3a shows that, as
expected, lower quality chips tend to have larger residuals
when fitting the RMA probe-level summarization model.
Similarly, Figures 3b and 3c show that low quality chips
are more likely to have higher variability in the RLE met-
ric. Interestingly, the SCORE.pos.vs.neg.auc metric, which
measures the area under an ROC curve discriminating
between positive and negative controls, did not indicate a
major difference between high and low quality chips. This
seems to be in conflict with the recommendation by
G
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Affymetrix that this is potentially one of the most useful
quality control indicators for exon arrays [61]. This obser-
vation could reflect the fact that labs detecting unusual
values for this metric may have been more likely to
exclude the corresponding chips from further analysis.
Classifier Performance Evaluation
3' Expression Arrays
After obtaining parameter estimates for various quality
control features for the 3' expression arrays, we next
sought to compare the performance of the unsupervised
and supervised classifiers. A 10-fold cross-validation pro-
cedure was used to compare the performance of naïve
Bayes classifiers constructed using distribution parameters
estimated using either the standard maximum likelihood
method or, alternatively, the unsupervised mixture model
approach. For each of 10 iterations, 9/10 of the 603 data
instances were used as a training set, for both parameter
estimation and also the selection of 5 classification fea-
tures. For classifiers built using supervised MLE estimation
("MLE + Naïve Bayes"), the expert generated labels were
used to distinguish between high and low quality chips in
the training set. For the unsupervised classifier ("EM +
Naïve Bayes"), the expert labels in the training set were
Comparison of Parameter Estimates for 3' Expression Arrays and Exon Arrays Figure 2
Comparison of Parameter Estimates for 3' Expression Arrays and Exon Arrays. Each diagram illustrates the unsu-
pervised Gaussian parameter estimates for one of the quality control features, for each of the two chip types. Estimates shown 
are for the following features: (A) Upper tail of the Relative Log Intensity (RLE), computed using the affyPLM functionality, (B) 
median of the raw intensity distribution, (C) 10th percentile of the probe-level model residuals, and (D) inter-quartile range of 
the RLE.BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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ignored and the EM algorithm was used to estimate
parameters of a Gaussian mixture model. The remaining
unused 10th of the data was used to assess the perform-
ance of the classifier, using the expert labels as the stand-
ard of truth. The performance of the two algorithms was
nearly identical. The confusion matrices (additional file 1:
Table S1) show the classification results for the two algo-
rithms using a classification threshold of 0.5. The accuracy
of the MLE + Naïve Bayes method was .907 with a false
positive rate of .058, while the accuracy of the EM + Naïve
Bayes method was .910 with a false positive rate of .079.
An ROC curve, constructed by varying the classification
threshold, is shown in Figure 4. The area under the ROC
curve (AUC) was .9455 for the unsupervised method and
.9402 for the supervised method. Although this perform-
ance is good, it is possible that these results could be
improved even more by identifying and using alternative
(other than normal) distributions to model one or more
of the classification features.
In many real world scenarios the amount of unlabeled
data available greatly exceeds the amount of expert-
Parameter Estimates for Exon Array Expression Console QC Features Figure 3
Parameter Estimates for Exon Array Expression Console QC Features. Shown are the parameter estimates 
obtained using the EM algorithm for various exon array quality control features available in the Affymetrix Expression Console 
software. Estimates shown are for the following features: (A) mean of the absolute deviation of the RMA probe level model 
residuals from the median across chips, (B) standard deviation of signal from positive control probesets after normalization, (C) 
standard deviation of signal from all probesets after normalization, and (D) area under ROC curve discriminating between pos-
itive control probesets and negative controls.BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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labeled data. To test the performance of the two classifiers
under these conditions, we performed additional 10-fold
cross-validation experiments similar to the previous test.
However, in this case, the supervised MLE + Naïve Bayes
classifier was trained using random subsets of instances
from each labeled training fold, while the EM + Naïve
Bayes classifier was constructed using the entire unlabeled
training fold. Subsets containing 10, 20, 30, 60, 75, and
100 instances were used to train the supervised classifier.
The ROC curves in Figure 4 indicate that the EM + Naïve
Bayes classifier appears to have an advantage when the
amount of unlabeled training data available greatly
exceeds the amount of expert-labeled data. For example,
the unsupervised method clearly outperforms the super-
vised method when 30 or fewer labeled instances were
available. Table S2 (available in additional file 1) contains
the resulting confusion matrix for the case in which 30
labeled training instances were used, with a classification
threshold of 0.5.
3' Exon Arrays
To demonstrate the general applicability of our method,
we constructed unsupervised classifiers using the two sets
of quality control variables and the entire unlabeled train-
ing set. These classifiers were then used to predict classifi-
cation labels for each data point. Figure S6 (in additional
file 1) shows a Venn diagram comparing the classification
results for classifiers constructed using the BioConductor
quality features and the Expression Console quality fea-
tures. In most, but not all, cases, the classifiers agree on
the characterization of each chip with regard to quality. In
addition, both classifiers agree that approximately 39% of
the data is low quality. Additional file 3 contains the clas-
sification labels obtained using unsupervised classifiers
constructed using each set of quality variables.
Simulation Results
The agreement between the quality control feature distri-
bution parameters estimated using the supervised maxi-
mum likelihood method and the estimates obtained with
the unsupervised Gaussian mixture model suggests that
our domain expert has uncovered a plausible dichotomy
of chips within our dataset. To further confirm that the
chips classified as having low quality were indeed more
likely to negatively impact tests for differential expression,
we performed a simple simulation. The procedure
involved adding an offset to the observed expression
measurements for a subset of the probesets on a set of
"treatment" arrays, and then comparing these arrays with
a set of unmodified "control" arrays sampled from the
same experiment (details not shown). Among those chips
designated by the expert as low quality, the majority
(approximately 70%) impaired the ability to detect simu-
lated differential expression when included in an analysis,
compared to only about 10% of the chips classified as
having high quality.
Conclusion
In this paper we have illustrated the efficacy of an unsu-
pervised classification approach to assessing microarray
data quality. Our method uses unlabeled training data to
identify apparent distinctions between "good" and "bad"
quality chips within the dataset. The method then inte-
grates measurements obtained across a variety of quality
dimensions into a single composite quality score which
can be used to accurately identify low quality data.
Our method is flexible and can be easily adapted to
accommodate alternate quality statistics and platforms.
Because this technique requires only unannotated train-
ing data, it is easy to keep the resulting classifier up-to-
date as technology evolves, and the adaptable nature of
the system makes arbitrary, universal quality score thresh-
olds unnecessary. Moreover, since a naïve Bayes classifica-
tion approach involves the estimation of the underlying,
univariate distributions for each of the classification
parameters, this method allows for intuitive explanations
that offer an advantage over other "black box" classifica-
tion systems [66,67]. For example, under this framework,
it is possible to infer which diagnostic plots and features
are most relevant for the classification of a particular chip.
These plots can then be presented to the user in order to
explain the classification. A quality control method that
Classifier Performance Figure 4
Classifier Performance. Unsupervised versus supervised 
classifier using labeled data sets of various sizes. When the 
full labeled training dataset (~540 labeled instances per fold) 
is available, the performance of the unsupervised classifica-
tion method (EM+Naïve Bayes) and the supervised classifica-
tion method (MLE+Naïve Bayes) are equivalent on the test 
dataset. When the amount of labeled data is limited, but unla-
beled data is abundant, the unsupervised method outper-
forms the supervised method.BMC Bioinformatics 2009, 10:191 http://www.biomedcentral.com/1471-2105/10/191
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incorporates an interpretation of standard diagnostic
plots is an extension of a familiar process already used by
many labs, and good diagnostic plots can provide power-
ful and convincing evidence of data quality artifacts.
An important caveat for this, and any quality control
methodology, is that the decision about what to do with
the detected low quality chip(s) is dependent on the
experimental design, the number of low quality chips
detected, and the magnitude of the defects encountered.
In many cases, low quality chips still contain valuable
information, and in some cases the most effective strategy
may be to simply down-weight these chips rather than dis-
carding them entirely [68].
Nevertheless, with the availability of a variety of rapidly
growing public repositories for microarray data, the con-
tinual appearance of new microarray chip types, and the
increasing usage of genomics data by research organiza-
tions worldwide, the development of robust and flexible
methods for microarray quality assessment is now more
important than ever. An advantage of the approach
described in this paper is that, once a classifier has been
constructed, the run-time required to automatically clas-
sify new instances is minimal. This makes the method
ideal for use as a component of a batch processing system,
such as a screening tool for use with public databases, or
as a step in a meta-analysis pipeline.
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